Can Buying Ginkgo Bioworks Holdings Inc (NYSE: DNA) Still Be Worthwhile?

Ginkgo Bioworks Holdings Inc (NYSE:DNA) does about 33.60M shares in volume on a normal day but saw 70540645 shares change hands in Monday’s trading. The company now has a market cap of 1.75B USD. Its current market price is $0.84, marking an increase of 10.49% compared to the previous close of $0.76. The 52 week high reached by this stock is $2.55 whilst the lowest price level in 52 weeks is $0.72.

Ginkgo Bioworks Holdings Inc (DNA) has a 20-day trading average at $0.8824 and the current price is -66.97% off the 52-week high compared with 16.73% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.0234 and its 200-day simple moving average is $1.4615. If we look at the stock’s price movements over the week, volatility stands at 11.29%, which increases to 12.12% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 43.89 to suggest the stock is neutral.

The consensus objective for the share price is $1.62, suggesting that the stock has a potential upside of 48.15% over the period.

Raymond James also downgraded the stock to “Mkt Perform” from Outperform on November 14, 2023 at a price target of $3.50-$2.50.

Ginkgo Bioworks Holdings Inc (DNA) stock is down -14.92% over the week and -16.76% over the past month. Its price is -50.25% year-to-date and -36.79% over the past year.

The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -0.09 below consensus estimates by -0.01. The company’s next earnings report forecasts estimating quarterly EPS at -0.08 and -0.31 for whole year. Expected sales for next quarter are $51.29M, which analysts say will come at $199.27M for the current fiscal year and next year at $264.64M. In addition, estimates put the company’s current quarterly revenue at an average of $46.64M.

To reach the target analysts have set, the stock logically needs to grow 48.15 percent from here.

The company has a return on investment of -69.88% and return on equity of -65.81%. The beta has a value of 1.38. Price to book ratio is 1.63 and price to sales ratio is 8.39.